Statistics from Altmetric.com
Dr. Zerhouni, director of the National Institutes of Health (NIH), recently unveiled his vision for the restructuring of clinical and translational research.1In this plan, academic centers would function as homes that combine basic science, clinical research, and training under an infrastructure supported by Clinical and Translational Science Awards (CTSAs; RFA-RM-06-002).2A major component of the CTSA involves the training of a new generation of clinical and translational researchers. Such training requires infrastructural support and a core of experienced mentors. I and many of my colleagues are concerned that insufficient emphasis is being given to the support of clinical research mentoring. Even with very substantial progress over the last decade and the development of several new NIH programs and awards with an emphasis on clinical or patient-oriented research training, more can be accomplished. Now represents an opportune time to dispense with existing myths and start afresh.3,4
Myth 1: The NIH, through the CTSA, K-series, T-series, and other award programs, provides ample support for mentors.
Aside from the K24 mechanism (see below), NIH awards with a mentoring component rarely provide support for protected time for the mentors. The request for applications (RFA) for the Institutional Clinical and Translational Science Award cites the word mentor (or mentored, mentoring, mentors) 61 times. Yet under the U54 CTSA RFA, …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.